目的评价新型自由基清除剂——依达拉奉注射液治疗急性脑梗死的疗效。方法选择发病在72h内的急性脑梗死60例,随机分为观察组和对照组,对照组采用常规抗血小板聚集、改善循环等治疗,观察组在对照组治疗的基础上加用依达拉奉静脉滴注,观察两组治疗效果。结果观察组总有效率为93.3%,高于对照组的70.0%,差异有统计学意义(P<0.05);两组均未发现明显不良反应。结论依达拉奉治疗急性脑梗死疗效显著,且不良反应少。 Objective To evaluate the efficacy of a new free radical scavenger-edaravone injection in the treatment of acute cerebral infarction. Methods Sixty patients with acute cerebral infarction within 72 hours were randomly divided into observation group and control group. Conventional anti-platelet aggregation and circulation improvement were used in the control group. In the control group, edaravone Intravenous drip, observe the treatment effect of two groups. Results The total effective rate in the observation group was 93.3%, which was higher than that in the control group (70.0%), the difference was statistically significant (P <0.05). No obvious adverse reactions were found in both groups. Conclusion Edaravone is effective in treating acute cerebral infarction with less adverse reactions.